Breast Lift Surgery in India and UAE | Complete Patient Guide

Q: What is the cost of Breast Lift Surgery (Mastopexy) in India versus the UAE?

The cost of Breast Lift Surgery (Mastopexy) depends significantly on the surgical technique selected, whether it is combined with breast augmentation (implants or fat grafting), the specific hospital tier, and the surgeon's level of expertise. In India, at NABH- and JCI-accredited hospitals partnered with GAF Healthcare, the total cost of an isolated mastopexy (including surgeon fees, anaesthesiologist, operating theatre, 1–2 nights hospital stay, standard post-operative medications, and compression brassiere) ranges from approximately USD $1,800 to $4,500. Augmentation-mastopexy (with silicone implants) typically adds USD $800–$2,000 to these figures for implant cost. In the UAE (Dubai and Abu Dhabi), at JCI- and DHA/DoH-accredited private hospitals, the same procedure ranges from approximately USD $4,000 to $9,000 for isolated mastopexy, reflecting the premium private healthcare infrastructure, luxury patient-accommodation standards, and higher operating costs of the Gulf market. India is therefore typically 40–60% more affordable than the UAE for equivalent surgical outcomes. GAF Healthcare provides a personalised cost estimate inclusive of all clinical and logistical components before any financial commitment is made by the patient.

Q: How long do I need to stay in the country before I am fit to fly home after Breast Lift Surgery?

The minimum recommended in-country stay after Breast Lift Surgery (Mastopexy) is 2 weeks (14 days) from the date of surgery before undertaking a short- or medium-haul flight (under 6 hours). For long-haul intercontinental flights (6 hours or more — for example, India to the UK, UAE to Australia, or India to Canada), the operating surgeon's clinical clearance is required, and this is typically not issued until at least 3–4 weeks post-operatively. The reasons for this timeline are clinically specific: in the first 2 weeks, the risk of wound dehiscence at tension points (particularly the T-junction in Wise-pattern/anchor mastopexy) remains elevated; cabin pressure changes and prolonged immobility at altitude increase the risk of deep vein thrombosis (DVT), especially in patients who have undergone general anaesthesia; and swelling (oedema) and bruising must be stable enough that any new symptoms can be clinically distinguished from early complications. GAF Healthcare's operating surgeon issues a formal 'Fit to Fly' certificate at the final pre-departure wound review (typically Day 10–14). Patients are advised not to pre-book non-refundable return flights for fewer than 14 days post-surgery, and to purchase travel insurance that covers post-operative medical eventualities. For augmentation-mastopexy (combined implant and lift surgery), the minimum in-country stay is extended to 3 weeks given the additional dissection and recovery requirements.

Q: What is the success rate of Breast Lift Surgery (Mastopexy) and how long do the results last?

Breast Lift Surgery (Mastopexy) has a high patient satisfaction rate of 91–95% in peer-reviewed outcome studies and in BREAST-Q validated post-operative surveys conducted at high-volume plastic surgery centres. 'Success' in mastopexy is defined by multiple parameters: achievement of the planned nipple-areola complex (NAC) elevation to the target position (typically 19–21 cm from sternal notch), maintenance of breast shape and projection at 12 months, scar quality scoring, and patient-reported quality-of-life improvement. The overall surgical complication rate at JCI/NABH/DHA-accredited centres is below 5% for major complications (haematoma, wound infection, NAC compromise) and approximately 8–12% for minor complications (temporary sensory change, minor wound healing delay). In terms of longevity, mastopexy results are durable but not permanent — gravitational effects, ageing, hormonal changes, and fluctuations in body weight will continue to act on the breast over time. Studies show that at 5 years, approximately 85% of patients maintain a clinically satisfactory result. Durability is significantly enhanced by: maintaining stable body weight, avoiding future pregnancy (or understanding that pregnancy may reverse the result), using a supportive brassiere during high-impact activities, and — where an internal GalaFLEX P4HB bioabsorbable scaffold was used — the collagen matrix reinforcement laid down during mesh resorption provides additional long-term parenchymal support beyond what skin closure alone achieves. Patients with severe Grade III ptosis and significantly lax, thin skin have a higher risk of re-ptosis over time and should be counselled on this by their surgeon during the pre-operative consultation facilitated by GAF Healthcare.

Breast Lift Surgery in India

Get Breast Lift Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.

Breast Lift Surgery in UAE

Breast Lift Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.

Overview

Breast Lift Surgery (Mastopexy) is a precision cosmetic-reconstructive procedure that repositions descended breast tissue, removes excess skin, and reshapes the mammary envelope to restore a youthful, projected contour — with reported patient satisfaction rates consistently above 90% in high-volume centres. International patients choose India and the UAE through GAF Healthcare because both destinations offer board-certified plastic surgeons trained at globally accredited institutions, state-of-the-art operating theatres, and total treatment costs that represent a fraction of what the same procedure commands in the United States, United Kingdom, or Australia. GAF Healthcare coordinates every clinical and logistical detail — from pre-operative imaging and surgeon matching to post-operative physiotherapy and fit-to-fly certification — ensuring patients travel with confidence and return home safely.

Hospital Stay: 1–2 days (day-surgery or overnight admission; longer if combined with augmentation or reduction) • Total Stay in Country (Fit-to-Fly): 2–3 weeks minimum before short/medium-haul flights; 3–4 weeks recommended for long-haul intercontinental travel • Success Rate: 91–95% patient satisfaction; complication rates below 5% at JCI/NABH/DHA-accredited centres

What Is It?

Breast ptosis — the clinical term for breast sagging — is a multifactorial anatomical condition characterised by inferior descent of the nipple-areola complex (NAC) relative to the inframammary fold (IMF), loss of upper-pole breast volume, and elongation of the skin envelope. It is graded using the Regnault Classification: Grade I (mild ptosis, nipple at the IMF level), Grade II (moderate ptosis, nipple 1–3 cm below the IMF), Grade III (severe ptosis, nipple more than 3 cm below the IMF and pointing inferiorly), and pseudoptosis (nipple above the IMF but with significant inferior pole gland descent). Causative factors include pregnancy, breastfeeding-related glandular involution, significant weight loss, hormonal changes at menopause, and gravitational effects on a large or heavy breast over time. Beyond aesthetics, clinically significant ptosis can cause chronic inframammary intertrigo, postural discomfort, brassiere-strap grooving of the shoulders, and psychosocial distress that measurably impairs quality-of-life scores on validated instruments such as the BREAST-Q questionnaire.

Mastopexy addresses these concerns by surgically elevating and reshaping the breast parenchyma, excising redundant skin, and repositioning the NAC to a more anatomically superior, aesthetically pleasing location — typically 19–21 cm from the sternal notch and at the level of the mid-humerus. The procedure does not inherently add volume; if volume loss is a concurrent concern, mastopexy is combined with implant augmentation (augmentation-mastopexy) or autologous fat grafting using precision-harvested adipose tissue processed through closed-loop systems such as the Revolve or LipoKit platforms.

The standard of care at JCI-accredited centres in India and the UAE includes pre-operative three-dimensional digital surface imaging (e.g., Vectra XT or Crisalix VR simulation) to set realistic patient expectations, intraoperative use of tumescent infiltration with dilute epinephrine and lidocaine to minimise blood loss, and layered closure with long-acting absorbable sutures (e.g., PDS II or Monocryl) to reduce tension on cutaneous scars. Perioperative anaesthesia protocols combine propofol-based total intravenous anaesthesia (TIVA) with multimodal analgesia — including local anaesthetic blocks, NSAIDs, and low-dose opioid sparing — to facilitate same-day or next-morning discharge and reduce post-operative nausea.

Candidates

• IDEAL CANDIDATES:

• Women aged 18 or older with fully developed breasts and stable body weight (within 10–15 kg of goal weight) for at least 6–12 months

• Regnault Grade I, II, or III ptosis confirmed on clinical examination with NAC-to-IMF measurements

• Patients who have completed childbearing, or who understand that future pregnancy can reverse surgical results

• Non-smokers, or patients willing to abstain from nicotine (cigarettes, vaping, nicotine patches) for a minimum of 4 weeks pre-operatively and 4 weeks post-operatively — nicotine causes microvascular vasoconstriction and dramatically elevates the risk of NAC necrosis and wound dehiscence

• BMI ≤ 32 kg/m² (patients with BMI 32–35 may be considered case-by-case with documented stable weight and no comorbid coagulopathy)

• Psychologically stable with realistic, documented expectations assessed via standardised BREAST-Q pre-operative survey

• No active breast malignancy — all candidates over 35 must provide a current mammogram (within 12 months) and/or breast ultrasound; those with BRCA1/BRCA2 carrier status require multidisciplinary oncology clearance before elective mastopexy

• REQUIRED DIAGNOSTIC WORKUP (PERFORMED PRE-OPERATIVELY):

• Mammogram (digital or tomosynthesis) and/or breast ultrasound: mandatory for patients ≥ 35 years or any age with a palpable mass or family history of breast cancer

• Full blood count (FBC), coagulation screen (PT/aPTT/INR), metabolic panel, fasting glucose, HbA1c

• Urine pregnancy test (mandatory for all women of reproductive age on day of surgery)

• Baseline ECG for patients over 40 or those with cardiac history; anaesthesiology ECHO clearance if clinically indicated

• Preoperative 3D digital imaging (Vectra XT or Crisalix) for surgical planning and expectation alignment — standard at GAF Healthcare partner hospitals

• Patch testing if synthetic mesh (e.g., GalaFLEX P4HB scaffold) is planned for parenchymal support

• CONTRAINDICATIONS (ABSOLUTE):

• Active or recently treated breast malignancy without oncology clearance

• Active systemic infection or skin infection overlying the breast

• Uncontrolled diabetes mellitus (HbA1c > 8.0%)

• Untreated coagulopathy or current anticoagulant therapy that cannot be safely bridged

• Active smoker unwilling to cease nicotine at least 4 weeks pre-operatively

• Autoimmune connective tissue disorders with significant microvascular involvement (relative contraindication — requires rheumatology clearance)

• Unrealistic expectations or untreated body dysmorphic disorder (BDD) — BDD screening using the BDDQ instrument is mandatory at GAF Healthcare partner centres

Procedure

MASTOPEXY TECHNIQUES — SELECTED BY PTOSIS GRADE AND BREAST MORPHOLOGY:

1. PERIAREOLAR (BENELLI / ROUND-BLOCK) MASTOPEXY

Indicated for Grade I (mild) ptosis or pseudoptosis with minimal skin excess. A single doughnut-shaped excision is made around the areola; the NAC is elevated and the surrounding skin advanced and purse-string sutured with a permanent or long-lasting absorbable suture (e.g., 2-0 Gore-Tex or PDS). The scar is entirely confined to the areolar border (peri-areolar scar). Limitation: prone to areolar spreading and radial wrinkling if used beyond mild ptosis.

2. VERTICAL (LOLLIPOP) MASTOPEXY — Hall-Findlay or Lejour Technique

The workhorse procedure for Grade II (moderate) ptosis. Incisions are periareolar plus a vertical limb running from the NAC to the IMF. The medial and lateral breast pillars are sutured together to create an internal brassiere of parenchymal tissue (auto-augmentation), elevating and reshaping the breast cone without implants. Scars: periareolar ring + vertical line. This technique avoids the horizontal IMF scar and is preferred in patients with good skin elasticity.

3. WISE-PATTERN (ANCHOR / INVERTED-T) MASTOPEXY

Gold-standard for Grade III (severe) ptosis or cases with significant horizontal skin excess. Combines periareolar, vertical, and horizontal IMF incisions. Provides the greatest degree of lift, reshaping, and NAC repositioning. Scars form an anchor pattern. Highest scar burden but most powerful correction — appropriate for large, heavy, or significantly descended breasts.

4. AUGMENTATION-MASTOPEXY (COMBINED PROCEDURE)

For patients with concurrent volume loss and ptosis. A cohesive silicone gel implant (form-stable 'gummy bear' implants, e.g., Mentor MemoryShape or Allergan Natrelle 410) or round high-projection implants are placed in a dual-plane (submuscular-subglandular) pocket simultaneously with the mastopexy. Alternatively, autologous fat grafting (Coleman lipofilling technique) using structured fat transfer is used to restore upper-pole volume without a foreign implant — increasingly preferred in patients who decline implants. This combination carries a higher complication risk than either procedure alone and requires a surgeon with specific combined-procedure experience.

5. AUTO-AUGMENTATION MASTOPEXY (IMPLANT-FREE VOLUME REDISTRIBUTION)

The inferior pole parenchymal flap (de-epithelialised) is folded upward and sutured to the pectoralis fascia to fill the upper pole — providing a modest volume effect without a prosthesis. Best suited for patients with Grade II–III ptosis and adequate existing breast volume. Techniques include the Hall-Findlay superolateral pedicle variant and the Góes periareolar approach with mesh support.

6. MASTOPEXY WITH BIOABSORBABLE INTERNAL SCAFFOLD (GALAFLEX P4HB MESH)

Next-generation approach where a knitted poly-4-hydroxybutyrate (P4HB) mesh scaffold (GalaFLEX) is sutured to the breast parenchyma to provide durable internal support, reducing the risk of long-term re-ptosis. The mesh is fully absorbed over approximately 18–24 months, by which time collagen ingrowth has consolidated the new breast shape. Particularly valuable in patients with thin, lax skin or in revision mastopexy cases.

7. NIPPLE-AREOLA COMPLEX (NAC) MANAGEMENT TECHNIQUES

• Free nipple graft (FNG): Reserved for severe macromastia-associated ptosis where the NAC must travel more than 15–20 cm; sensory recovery is variable.

• Superior pedicle, medial pedicle, or superomedial pedicle: Standard vascularised pedicle techniques that preserve sensation and lactation potential; pedicle selection depends on NAC transposition distance and surgeon training.

ANESTHESIA AND TECHNOLOGY:

• Total Intravenous Anaesthesia (TIVA) with BIS (Bispectral Index) monitoring for depth of anaesthesia

• Tumescent infiltration: Dilute lidocaine 0.05% + epinephrine 1:400,000 for haemostasis

• Intraoperative harmonic scalpel or LigaSure vessel sealing for reduced blood loss

• Postoperative cryotherapy units and compression brassiere fitting before discharge

• Enhanced Recovery After Surgery (ERAS) protocols: multimodal analgesia (paracetamol, ketorolac, dexamethasone, low-dose opioid PRN), early ambulation, anti-emetic prophylaxis (ondansetron + dexamethasone)

Cost of Breast Lift Surgery: India vs. UAE

The total cost of Breast Lift Surgery (Mastopexy) varies based on the surgical technique selected (periareolar, vertical, or anchor/Wise-pattern), whether the procedure is combined with implant augmentation or fat grafting, the tier of hospital facility chosen, and the surgeon's level of subspecialty expertise. India consistently offers the lowest cost globally among high-quality accredited destinations — typically 40–60% below UAE pricing and 60–80% below US or UK pricing — while maintaining surgical outcomes at internationally benchmarked standards. The UAE (Dubai and Abu Dhabi) offers premium private hospital environments with concierge-level service, a regulatory framework overseen by the Dubai Health Authority (DHA) and Department of Health Abu Dhabi (DoH), and geographic accessibility for patients travelling from Europe, East Africa, and the Gulf region. Both destinations through GAF Healthcare include surgeon fees, anaesthesiologist fees, operating theatre costs, one to two nights of hospital accommodation, standard post-operative medications (analgesics, antibiotics, anti-emetics), and the compression support brassiere. Implant or GalaFLEX scaffold costs are additional where applicable.

Destination	Estimated Cost (USD)	Key Advantage
India	$1,800 – $4,500	~52% less than the UAE
UAE (Dubai/Abu Dhabi)	$4,000 – $9,000	Premium care, JCI/DHA accredited

Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.

Recovery & Aftercare

PHASE 1 — PRE-OPERATIVE PREPARATION (4–8 WEEKS BEFORE SURGERY)

• Step 1 (Remote): Patient submits medical history, photographs, and mammogram/ultrasound reports via the GAF Healthcare secure patient portal. A GAF-affiliated plastic surgeon reviews the case and issues a personalised surgical recommendation specifying technique (e.g., vertical mastopexy with superomedial pedicle), implant requirement (if any), and estimated operative time.

• Step 2 (Remote): GAF Healthcare arranges a video consultation with the operating surgeon for expectation alignment and 3D simulation (Crisalix VR images shared digitally).

• Step 3 (On Arrival — Day 1–2): Patient arrives at the GAF Healthcare partner hospital or clinic. In-person physical examination, breast measurements (sternal notch-to-nipple distance, base width, IMF mapping), blood tests, mammogram (if not recently performed), ECG, and anaesthesia pre-assessment are completed.

• Step 4 (Day 2–3, Pre-Op): Surgeon performs detailed surgical markings in the upright standing position with permanent marker — a critical step unique to breast surgery where gravity must be accounted for. Patient signs informed consent covering all technique-specific risks. Pre-operative BREAST-Q completed.

• Smoking cessation, aspirin/NSAID/herbal supplement cessation (minimum 2 weeks pre-op), and compression brassiere pre-fitting are completed.

PHASE 2 — SURGERY DAY

• Step 5 (Day 3–4): Patient admitted 2 hours before surgery. IV cannula inserted; anaesthesia team administers premedication (midazolam 1–2 mg IV, ondansetron 4 mg IV). Surgeon performs final standing markings review.

• Step 6: TIVA induction with propofol and remifentanil; airway secured with laryngeal mask airway (LMA) or endotracheal tube for combined procedures. Tumescent infiltration applied.

• Step 7: Surgical procedure performed — typical operative time: 2–2.5 hours for isolated mastopexy; 3–4 hours for augmentation-mastopexy. Layered wound closure; drains placed only if significant dissection performed (most isolated mastopexies are drain-free). Compression brassiere applied in theatre.

• Step 8: Recovery room monitoring for 1–2 hours. Oral fluids commenced. Pain assessed using NRS (Numeric Rating Scale); multimodal analgesia initiated. Most patients are ambulant within 4 hours of surgery.

PHASE 3 — IMMEDIATE POST-OPERATIVE PERIOD (Days 1–14 In-Country)

• Day 1 post-op: Overnight admission for monitoring (vital signs, wound inspection, fluid balance). Shower and gentle mobilisation permitted Day 1 post-op with waterproof dressing. Compression brassiere worn 24/7.

• Day 3–5: First wound review. Sutures are absorbable (Monocryl/PDS); no suture removal required in most cases. Early scar management with silicone gel sheets initiated. Bruising and swelling (oedema) are expected and peak at 72 hours.

• Day 7: Second wound review, lymphatic drainage massage initiated if indicated. Patient given written fit-to-travel assessment criteria.

• Day 10–14: Final pre-departure review. Surgeon issues a 'fit-to-fly' certificate with specific instructions: compression brassiere for travel, avoiding prolonged arm elevation, and DVT prophylaxis guidance (hydration, compression stockings, low-molecular-weight heparin if risk-stratified as high-risk).

PHASE 4 — RECOVERY MILESTONES (POST-OPERATIVE WEEKS 2–12)

• Week 2: Return to sedentary desk work; driving can resume once arm movement is full and pain-free (typically Week 3–4).

• Week 3–4: Fit for short/medium-haul flight (< 6 hours). Long-haul intercontinental travel recommended after Week 4 minimum.

• Week 4–6: Light walking and lower-body exercise permitted. Upper body, chest, and pectoral exercises strictly avoided until Week 8.

• Week 6: Compression brassiere may be replaced with a supportive sports bra. Scar maturation begins; silicone sheets or gels continued for 6–12 months.

• Week 8: Return to gym (non-chest exercises). Underwire brassiere can be reintroduced.

• Week 12: Final shape begins to consolidate as swelling fully resolves. Upper-pole softening stabilises. BREAST-Q post-operative survey completed at 3 months.

• Month 6–12: Scars continue to fade from pink/red to pale. Full scar maturation takes 12–18 months. GalaFLEX (if used) fully resorbed and replaced by native collagen scaffold.

Risks & Considerations

Mastopexy is a safe and well-established procedure when performed by a board-certified plastic surgeon in an accredited facility, but it carries both general anaesthetic risks and procedure-specific surgical risks that every patient must understand and consent to before proceeding.

SURGERY-SPECIFIC RISKS:

Top Hospitals for Breast Lift Surgery

The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.

🇮🇳

All India Institute of Medical Sciences (AIIMS)

New Delhi, India

NABH

🇮🇳

Kokilaben Dhirubhai Ambani Hospital

Mumbai, India

JCI NABH

🇮🇳

Christian Medical College (CMC)

Vellore, India

NABH ISO

🇮🇳

Manipal Hospitals Dwarka

New Delhi, India

NABH NABL

Top Doctors for Breast Lift Surgery

Internationally trained specialists in Cosmetic Surgery. Review their profiles, compare experience, and connect directly through GAF Healthcare.

Dr. Kanchan Kaur

MBBS, MS (General Surgery), MRCS

Surgical Oncologist (Breast)

Medanta - The Medicity, Gurgaon, India

22+ Yearsof experience

Dr. Kanchan Kaur is a senior breast cancer and general surgeon who serves as Senior Director — Breast Cancer at the Cancer Care division of Medanta – The Medicity, Gurgaon. With more than two decades of surgical experience, she has built a multidisciplinary breast practice that combines oncologic clarity with deep patient empathy. Dr. Kanchan is widely respected for her work in breast cancer awareness and early detection. She works closely with several… Read more

Dr. Ananya Deori

MCh, MS, MBBS

Breast Surgeon

Medanta - The Medicity, Delhi NCR, India

9+ Yearsof experience

Dr. Ananya Deori is an Associate Consultant in Breast Surgery at Medanta - The Medicity in Delhi NCR, bringing over 9 years of specialized surgical experience to the field of breast oncology. She holds an MCh degree in Breast and Endocrine Surgery from AIIMS Rishikesh, one of India's premier medical institutions, complemented by postgraduate qualifications in General Surgery. Her training in one of the country's most rigorous breast surgery programs has… Read more

Dr. Swathi Prakash

MCh, MS, MBBS

Breast Surgical Oncologist

Rela Hospital, Chennai, India

15+ Yearsof experience

Dr. Swathi Prakash is a Consultant in Breast Surgery and Surgical Oncology at Rela Hospital in Chennai, with over 15 years of clinical experience. She holds an MCh in Breast & Endocrine Surgery from All India Institute of Medical Sciences (AIIMS), New Delhi, and was the first in Tamil Nadu to achieve this distinction in breast surgery. Her comprehensive training encompasses both benign and malignant breast disease management, underpinned by rigorous… Read more

Dr. Mansi Chowhan

MBBS, MS (General Surgery) – Gold Medalist, MCh Breast Oncoplasty, Fellowship in Breast Surgery, Global Fellowship IFHNOS, FIAGES – Fellow of Indian Association of Gastro Endoscopic Surgeons, Observership – Breast Unit

Oncoplastic Breast Surgeon

Fortis Hospital Manesar, Gurugram, India

14+ Yearsof experience

Dr. Mansi Chowhan is an expert Oncoplastic Breast Surgeon with more than 14 years of experience and a gold medal during her surgical post-graduation. She is well-trained from world-renowned surgeons and cancer institutions including the Paris Breast Centre, Memorial Sloan Kettering Cancer Centre (New York), University of East Anglia (UK), and Tata Memorial Hospital, Mumbai. Her role as a Consultant in Surgical Oncology has been marked by dedication to… Read more

Dr. Aditi Chaturvedi

MBBS, MS, MCh

Breast and Oncoplastic Surgeon

Apollo Athenaa Women's Cancer Centre, New Delhi, India

13+ Yearsof experience

Dr. Aditi Chaturvedi is a Senior Consultant Breast and Oncoplastic Surgeon at Apollo Athenaa Women's Cancer Centre in New Delhi, bringing over 13 years of dedicated expertise in breast oncology and surgical reconstruction. A Fellow of the UICC at Memorial Sloan Kettering Cancer Center in New York, she holds postgraduate qualifications including MS in General Surgery and MCh in Surgical Oncology, positioning her at the forefront of breast cancer care in… Read more

Frequently Asked Questions — Breast Lift Surgery

The cost of Breast Lift Surgery (Mastopexy) depends significantly on the surgical technique selected, whether it is combined with breast augmentation (implants or fat grafting), the specific hospital tier, and the surgeon's level of expertise. In India, at NABH- and JCI-accredited hospitals partnered with GAF Healthcare, the total cost of an isolated mastopexy (including surgeon fees, anaesthesiologist, operating theatre, 1–2 nights hospital stay, standard post-operative medications, and compression brassiere) ranges from approximately USD $1,800 to $4,500. Augmentation-mastopexy (with silicone implants) typically adds USD $800–$2,000 to these figures for implant cost. In the UAE (Dubai and Abu Dhabi), at JCI- and DHA/DoH-accredited private hospitals, the same procedure ranges from approximately USD $4,000 to $9,000 for isolated mastopexy, reflecting the premium private healthcare infrastructure, luxury patient-accommodation standards, and higher operating costs of the Gulf market. India is therefore typically 40–60% more affordable than the UAE for equivalent surgical outcomes. GAF Healthcare provides a personalised cost estimate inclusive of all clinical and logistical components before any financial commitment is made by the patient.

The minimum recommended in-country stay after Breast Lift Surgery (Mastopexy) is 2 weeks (14 days) from the date of surgery before undertaking a short- or medium-haul flight (under 6 hours). For long-haul intercontinental flights (6 hours or more — for example, India to the UK, UAE to Australia, or India to Canada), the operating surgeon's clinical clearance is required, and this is typically not issued until at least 3–4 weeks post-operatively. The reasons for this timeline are clinically specific: in the first 2 weeks, the risk of wound dehiscence at tension points (particularly the T-junction in Wise-pattern/anchor mastopexy) remains elevated; cabin pressure changes and prolonged immobility at altitude increase the risk of deep vein thrombosis (DVT), especially in patients who have undergone general anaesthesia; and swelling (oedema) and bruising must be stable enough that any new symptoms can be clinically distinguished from early complications. GAF Healthcare's operating surgeon issues a formal 'Fit to Fly' certificate at the final pre-departure wound review (typically Day 10–14). Patients are advised not to pre-book non-refundable return flights for fewer than 14 days post-surgery, and to purchase travel insurance that covers post-operative medical eventualities. For augmentation-mastopexy (combined implant and lift surgery), the minimum in-country stay is extended to 3 weeks given the additional dissection and recovery requirements.

Breast Lift Surgery (Mastopexy) has a high patient satisfaction rate of 91–95% in peer-reviewed outcome studies and in BREAST-Q validated post-operative surveys conducted at high-volume plastic surgery centres. 'Success' in mastopexy is defined by multiple parameters: achievement of the planned nipple-areola complex (NAC) elevation to the target position (typically 19–21 cm from sternal notch), maintenance of breast shape and projection at 12 months, scar quality scoring, and patient-reported quality-of-life improvement. The overall surgical complication rate at JCI/NABH/DHA-accredited centres is below 5% for major complications (haematoma, wound infection, NAC compromise) and approximately 8–12% for minor complications (temporary sensory change, minor wound healing delay). In terms of longevity, mastopexy results are durable but not permanent — gravitational effects, ageing, hormonal changes, and fluctuations in body weight will continue to act on the breast over time. Studies show that at 5 years, approximately 85% of patients maintain a clinically satisfactory result. Durability is significantly enhanced by: maintaining stable body weight, avoiding future pregnancy (or understanding that pregnancy may reverse the result), using a supportive brassiere during high-impact activities, and — where an internal GalaFLEX P4HB bioabsorbable scaffold was used — the collagen matrix reinforcement laid down during mesh resorption provides additional long-term parenchymal support beyond what skin closure alone achieves. Patients with severe Grade III ptosis and significantly lax, thin skin have a higher risk of re-ptosis over time and should be counselled on this by their surgeon during the pre-operative consultation facilitated by GAF Healthcare.

Why Plan Your Treatment Through Gaf Healthcare?

GAF Healthcare provides a fully integrated medical tourism coordination service that extends well beyond surgical booking, addressing every non-clinical friction point that international patients face when travelling for elective procedures.

VISA ASSISTANCE:

• India: GAF Healthcare's coordination team assists patients in applying for the Indian e-Medical Visa (e-MV), which is processed online and typically approved within 1–4 business days. The e-MV allows a stay of up to 60 days (triple-entry) and is valid for patients travelling specifically for medical treatment. GAF provides the treating hospital's invitation letter, FRRO (Foreigners Regional Registration Office) registration guidance, and assistance with the Visa on Arrival process at designated international airports.

• UAE (Dubai/Abu Dhabi): Citizens of over 50 countries are eligible for visa-free entry or visa-on-arrival into the UAE for 30–90 days. For patients from countries requiring prior approval, GAF Healthcare liaises with the partner hospital's international patient office to issue a treatment-linked visa facilitation letter through the DHA or DoH patient pathway. Patients from GCC countries face no visa requirement.

AIRPORT TRANSFERS AND GROUND LOGISTICS:

• Private, air-conditioned vehicle transfers from arrival airport to hospital and return to airport at discharge — bookable for both the patient and accompanying attendant.

• For patients with limited mobility post-operatively, GAF arranges wheelchair assistance pre-notified to the airline and airport, and ensures vehicles are equipped with suitable seating for comfort post-surgery.

ACCOMMODATION FOR PATIENT AND ATTENDANT:

• GAF Healthcare has negotiated corporate rates with partner serviced apartments and hotels within 5–15 minutes of each treatment hospital, ranging from comfortable 3-star to luxury 5-star options based on patient preference and budget.

• Attendant accommodation within hospital (in-room cot or adjoining room) is arranged at the time of hospital booking.

• For the recovery period between hospital discharge and the fit-to-fly date, GAF arranges serviced apartments with access to cooking facilities, laundry, and 24-hour building security — essential for patients recovering over 2–3 weeks without family support infrastructure.

DEDICATED PATIENT COORDINATOR AND TRANSLATION:

• Every patient is assigned a dedicated GAF Healthcare Case Manager who is available via WhatsApp, email, and phone throughout the patient's journey — from initial inquiry through post-operative discharge.

• Medical interpreters (Arabic, Russian, French, Swahili, Bahasa, and other languages) are available on-site or via secure video link at partner hospitals.

• Medical records, discharge summaries, and follow-up instructions are translated into the patient's native language and shared digitally via the GAF secure portal for continuity of care with the patient's home country physician.

POST-DEPARTURE FOLLOW-UP:

• Virtual post-operative review consultations with the operating surgeon at 2 weeks, 6 weeks, and 3 months post-discharge are coordinated by GAF Healthcare.

• Scar management product kits (medical-grade silicone sheets and gel) are either dispensed at discharge or shipped internationally to the patient's home address.

Patients Also Explore

Other treatments commonly sought by patients considering Breast Lift Surgery.

LASIK Eye Surgery

Ophthalmology

Cataract Surgery

Ophthalmology

Cochlear Implant

ENT

Hyperthyroidism Treatment

ENT